Outlook Therapeutics Inc (NASDAQ: OTLK) Has Succeeded To Excite In 2025, The Stock Is Down -76.06% Year-To-Date
Outlook Therapeutics Inc (NASDAQ:OTLK)’s traded shares stood at 0.54 million during the last session, with the company’s beta value hitting 0.28. At the close of